주자독서환의 뇌기능 활성 및 신경세포 보호효과

키워드

참고문헌 (49)

1. Raymond D, "신경과학", pp.715~761 (1998), 정담
2. 전국한의과대학 병리학교실, "한방병리학", pp.27~31 (2001), 한의문화사
3. 조남근, "족삼리 자침이 혈압과 뇌혈류역학에 미치는 영향", 대한침구학회지, 16(4), pp.307~319 (1999)
4. 조남근, "용천혈의 자침 및 애구 시술이 혈압과 국소뇌혈류량에 미치는 영향", 대한침구학회지, 15(2), pp.227~236 (1998)
5. 배병철, "금석황제내경소문", pp.118~119 (1994), 성보사
6. 허준, "동의보감", pp.191~ (1999), 법인문화사
7. 허준, "동의보감", pp.190~ (1999), 법인문화사
8. 강혁수, "주자독서환의 아밀로이드베타로 유발된 생쥐 알츠하이머모델에 대한 효과", 대한한방내과학회지, 27(1), pp.253~264 (2006)
9. 강인탁, "알코올 중독에 대한 주자독서환의 학습능력향상 및 간손상회복 효과", 석사, pp.2007
10. Bederson J.B, "Rat middle cerebral artery occlusion: evaluation of the model and development of a neurologic examination", Stroke, 17(3), pp.472~476 (1996)
11. Nagasawa H, "Correlation between cerebral blood flow and histologic changes in a new rat model of middle cerebral artery occlusion", Stroke, 20(8), pp.1037~1043 (1989)
12. Mari M, "Evaluation of the estrogenic activities of some pesticides and their combinations using MtT", Se cell proliferation assay, 2006, pp.209(5), 413~421
13. Lockhart BP, "Conition enhancing or neuroprotective compounds for the treatment of cognitive disorders", why? when? which? Exp Gerontol, 38(1-2), pp.119~128 (2003)
14. Simard M, "Memory assessment in studies of cognition-enhancing drugs for Alzheimer's disease", Drugs Aging, 14(3), pp.197~230 (1999)
15. 김은선, "뇌질환 치료제Ⅰ, 산업시장분석", pp.25~55 (2006), 한국과학기술정보연구원
16. 나영신, "뇌혈관질환에서 SPECT와 PET의 임상적 응용", Nuclear Medicine and Molecular Imaging, 37(1), pp.1~12 (2003), 대한핵의학회
17. 대한신경외과학회, "신경외과학", pp.150~156 (1998), 중앙문화사
18. 이시진, "본초강목중국의학대계", pp.650~651 (1995), 여강출판사
19. 손사막, "비급천금요방. 중국의학대계", pp.896~898 (1995), 여강출판사
20. 허준, "동의보감", 법인문화사, pp.487~ (1999)
21. 이천, "의학입문", pp.126~ (1994), 의성당
22. 황도연, "신증방약합편", pp.376~ (2002), 영림사
23. Giacobini E, "From molecular structure to Alzheimer therapy", Jpn J Pharmacol, 74(3), pp.225~241 (1997)
24. Giacobini E, "Present and future of Alzheimer therapy", J Neural Transm Suppl, 59, pp.231~242 (2000)
25. Bachurin SO, "Medicinal chemistry approaches for the treatment and prevention of Alzheimer's disease", Med Res Rev, 23(1), pp.48~88 (2003)
26. Harris RJ, "Changes in extracellular calcium activity in cerebral ischemia", J.Cereb Blood Mrtab, pp.203~209 (2001)
27. 김우겸, "인체의 생리", pp.20~47 (1985), 서울대학교 출판부
28. Wang Q, "Comparison of the effects of NG-nitro- L-arginine and indomethacin on hypercapnic cerebral blood flow increase in rats", Brain Res, 641(2), pp.257~264 (1994)
29. Iwamoto J, "Methylene blue inhibits hypoxic cerebral vasodilation in awake sheep", J.Appl Physiol, 73(6), pp.2226~2232 (1992)
30. Okura Y, "Recombinant murine interleukin-12 facilitates induction of cardiac myosin-specific type 1 helper T cells in rats", Circ Res, 82(10), pp.1035~1042 (1998)
31. Ginsberg MD, "Neuroprotection for ischemic stroke: past, present and future", Neuro- pharmacology, 55(3), pp.363~389 (2008)
32. Buchan AM, "Hypothermia but not the N-methyl-D-aspartate receptor antagonist, MK-801, attenuates neuronal damage in gerbils subjected to transient global ischemia", J Neurosci, 11, pp.1049~1050 (1990)
33. Aronowski J, "Graded bioassay for demonstration of brain rescue from experimental acute ischemia in rats", Stroke, 25(11), pp.2235~2240 (1994)
34. Goldlust E.J, "Automated measurement of infarct size with scanned images of triphenyltetrazolium chloride-stained rat brains", Stroke, 27(9), pp.1657~1662 (1996)
35. Kerege F, "Low brain-derived neurotrophic factor(BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet activity", Biol Psychiatry, 57, pp.1068~1072 (2005)
36. Connor B, "The role of neuronal growth factors in neurodegenerative disorders of the human brain", Brain Res Reviews, 27(1), pp.1~39 (1998)
37. Legutko B, "Regulation of BDNF expressionin primary neuron culture by LY392098, a novel AMPA receptor potentiator", Neuropharmachology, 40(8), pp.1019~1027 (2001)
38. Cotman CW, "Exercise:a behavioral intervention to enhance brain health and plasticity", Trends Neurosci, 25(6), pp.295~301 (2002)
39. Gomez-Pinilla F, "A “deficient enviroment” in prenatal life may compromise systems important for cognitive function by affecting BDNF in the hippocampus", Exp Neurol, 192, pp.235~243 (2005)
40. Eichenbaum H, "The hippocampus and declaractive memory:cognitive mechanism and neural codes", Behav Brain Res, 127, pp.199~207 (2000)
41. Wills BK, "The effect of amifostine, a cytoprotective agent, on paraquat toxicity in mice", J Med Toxicol, 3(1), pp.1~6 (2007)
42. Krasowska A, "Cell-protective and antioxidant activity of two groups of synthetic amphiphilic compounds-phenolics and amine N-oxides", Folia Microbiol, 52(6), pp.585~592 (2007)
43. Mullens W, "Sodium nitroprusside for advanced low-output heart failure", J Am Coll Cardiol, 52(3), pp.200~207 (2008)
44. Molina-Jiménez MF, "Neuroprotective effect of fraxetin and myricetin against rotenone-induced apoptosis in neuroblastoma cells", Brain Res, 1009(1-2), pp.9~16 (2004)
45. Zhang JG, "Tirmenstein MA, Fariss MW. Vitamin E succinate protects hepatocytes against the toxic effect of reactive oxygen species generated at mitochondrial complexes I and III by alkylating agents", Chem Biol Interact, 138(3), pp.267~284 (2001)
46. Corpas FJ, "The expression of different superoxide dismutase forms is cell-type dependent in olive (Olea europaea L.) leaves", Plant Cell Physio, 47(7), pp.984~994 (2006)
47. Corpas FJ, "Peroxisomes as a source of reactive oxygen species and nitric oxide signal molecules in plant cells", Trends Plant, 6(4), pp.145~150 (2001)
48. Pompella A, "The changing faces of glutathione, a cellular protagonist", Biochem Pharmacol, 66(8), pp.1499~1503 (2003)
49. Pastore A, "Determination of blood total, reduced, and oxidized glutathione in pediatric subjects", Clin. Chem, 47(8), pp.1467~1469 (2003)

관련 논문AI추천